New York legislation · 2025-2026 General Assembly
New York A2126: Establishes a pilot program on upper payment limits for prescription drugs
Status: In committee, October 2, 2026
Establishes a pilot program on upper payment limits for prescription drugs; provides that an upper payment limit shall not be less than the maximum fair price for a drug published by the secretary of the US department of health and human services.
What the bill says
An act to amend the insurance law, in relation to requiring an upper payment limit for prescription drugs.
From the amended text, October 2, 2026:
AN ACT to amend the insurance law, in relation to requiring an upper payment limit for prescription drugs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS: Section 1. The insurance law is amended by adding a new section 111-b to read as follows: § 111-B. PILOT PROGRAM ON UPPER PAYMENT LIMITS FOR PRESCRIPTION DRUGS. (A) LEGISLATIVE FINDINGS AND DECLARATION; STATEMENT OF POLICY. THE LEGISLATURE HEREBY FINDS AND DECLARES THAT ACCESS TO PRESCRIPTION DRUGS IS NECESSARY FOR THE PUBLIC HEALTH, GENERAL WELFARE, AND ECONOMY OF THE STATE: (1) EXCESSIVE PRICES FOR PRESCRIPTION DRUGS THREATEN THE ECONOMIC WELL-BEING OF NEW YORK RESIDENTS AND ENDANGER THEIR ABILITY TO PAY FOR OTHER NECESSARY AND ESSENTIAL GOODS AND SERVICES INCLUDING HOUSING, FOOD AND UTILITIES; (2) EXCESSIVE PRICES FOR PRESCRIPTION DRUGS CONTRIBUTE SIGNIFICANTLY TO A DRAMATIC AND UNSUSTAINABLE RISE IN HEALTH CARE COSTS AND HEALTH INSURANCE THAT THREATEN THE OVERALL ABILITY OF NEW YORK RESIDENTS TO OBTAIN HEALTH COVERAGE AND MAINTAIN OR ACHIEVE GOOD HEALTH; (3) EXCESSIVE PRICES FOR PRESCRIPTION DRUGS CONTRIBUTE SIGNIFICANTLY TO RISING STATE COSTS FOR HEALTH CARE PROVIDED AND PAID FOR THROUGH EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD00232-08-6 A. 2126--B 2 HEALTH INSURANCE PROGRAMS FOR PUBLIC EMPLOYEES, INCLUDING EMPLOYEES OF THE STATE, …
Sponsors
- Sarahana Shrestha (D, 103) · primary sponsor
- Marcela Mitaynes (D, 51)
- Hermelyn, Rodneyse Bichotte (I, 42)
- Emily Gallagher (D, 50)
- Dana Levenberg (D, 95)
- William Colton (D, 47)
- Jo Simon (D, 52)
- Linda Rosenthal (D, 67)
- Karines Reyes (D, 87)
- Sarah Clark (D, 136)
- Donna Lupardo (D, 123)
- Christopher Burdick (D, 93)
Latest actions
- : PRINT NUMBER 2126B
- : AMEND (T) AND RECOMMIT TO INSURANCE
- : PRINT NUMBER 2126A
- : AMEND AND RECOMMIT TO INSURANCE
- : REFERRED TO INSURANCE
- : REFERRED TO INSURANCE
Subjects: Insurance Law
Common questions
- What is A2126?
- A2126 is a bill in the New York Legislature (2025-2026 General Assembly): Establishes a pilot program on upper payment limits for prescription drugs.
- What does A2126 do?
- In its own words: An act to amend the insurance law, in relation to requiring an upper payment limit for prescription drugs.
- What is the status of A2126?
- In committee as of October 2, 2026. Latest action: PRINT NUMBER 2126B (October 2, 2026).
- Who sponsored A2126?
- Sarahana Shrestha (D, 103), with 11 co-sponsors.
- Where is the official record for A2126?
- On the New York Legislature website: https://www.nysenate.gov/legislation/bills/2025/A2126
Source: official New York record. Tracked by Delilah, AI for legislation across all 50 states and Congress.